You WeonKyoo - ABL Bio Head MD
| 298380 Stock | KRW 26,000 400.00 1.52% |
Insider
You WeonKyoo is Head MD of ABL Bio
| Phone | 82 31 8018 9800 |
| Web | http://www.ablbio.com |
ABL Bio Management Efficiency
The company has return on total asset (ROA) of (0.3051) % which means that it has lost $0.3051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 5.5983 %, meaning that it generated $5.5983 on every $100 dollars invested by stockholders. ABL Bio's management efficiency ratios could be used to measure how well ABL Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | INSIDER Age | ||
| You Suh | Genexine | N/A | |
| Kyu Kim | Genexine | N/A | |
| Jungwon Woo | Genexine | N/A | |
| Sung Lee | Genexine | N/A | |
| Jae Park | Genexine | N/A | |
| Young Sung | Genexine | 67 | |
| JaiHyun Kwon | Genexine | N/A | |
| Sung CPA | Genexine | N/A | |
Management Performance
| Return On Equity | 5.6 | |||
| Return On Asset | -0.31 |
ABL Bio Leadership Team
Elected by the shareholders, the ABL Bio's board of directors comprises two types of representatives: ABL Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABL. The board's role is to monitor ABL Bio's management team and ensure that shareholders' interests are well served. ABL Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABL Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jung Kim, MD COO | ||
| Jaecheon Lee, MD CFO | ||
| Jae Jung, MD Discovery | ||
| Jong Kim, MD Devel | ||
| Sang Lee, Founder CEO | ||
| You WeonKyoo, Head MD | ||
| Jong Won, Head Devel |
ABL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ABL Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 5.6 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (6.16) % | |||
| Current Valuation | 866.33 B | |||
| Shares Outstanding | 45.3 M | |||
| Shares Owned By Insiders | 31.53 % | |||
| Shares Owned By Institutions | 12.89 % | |||
| Price To Sales | 101.38 X | |||
| Revenue | 5.33 B | |||
| Gross Profit | 8.06 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ABL Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ABL Bio's short interest history, or implied volatility extrapolated from ABL Bio options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABL Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |